Navigation Links
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual,Meeting

l thickness and mean macular volume throughout the 6 week observation period. The VEGF Trap-Eye was generally well tolerated, and there were no drug-related serious adverse events. Adverse events were mostly related to the injection procedure.

About the VEGF Trap-Eye

Vascular endothelial growth factor (VEGF) is a naturally occurring protein in the body whose normal role is to trigger formation of new blood vessels (angiogenesis) to support the growth of the body's tissues and organs. It has also been associated with the abnormal growth and fragility of new blood vessels in the eye, which lead to the development of wet AMD. The VEGF Trap-Eye is a fully human, soluble VEGF receptor fusion protein that binds all forms of VEGF-A along with the related placental growth factor (PlGF). The VEGF Trap-Eye is a specific and highly potent blocker of these growth factors. Blockade of VEGF, which can prevent abnormal blood vessel formation and vascular leak, has proven beneficial in the treatment of wet AMD. Blocking VEGF has been shown to be effective in patients with wet AMD; and a VEGF inhibitor, ranibizumab, has been approved for treatment of patients with this condition.

About AMD

Age-related macular degeneration (AMD) is a leading cause of acquired blindness. Patients with this condition can experience a loss of vision due to the development of abnormal, fragile blood vessels in the back of the eye. A particular type of AMD, called wet AMD, accounts for approximately 90% of AMD-related blindness. Wet AMD is the leading cause of blindness for people over the age of 65 in the U.S. and Europe.

Macular degeneration is diagnosed as either dry (nonexudative) or wet (exudative). In wet AMD, new blood vessels grow beneath the retina and leak blood and fluid. This leakage causes disruption and dysfunction of the retina creating blind spots in central vision, and it can account for blindness in wet AMD patients.

About DME

Diabetic Mac
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: VEGF Trap Eye Phase Wet AMD Results Reported ARVO Annual Meeting
(Date:4/28/2015)... Semler Scientific, Inc. (Nasdaq: SMLR ), ... and markets patented products that assist healthcare providers in ... it has received an order from another one of ... offer Medicare Advantage programs. This brings the total count ... are now customers of Semler. It is ...
(Date:4/28/2015)... 2015 As the "Official Joint Replacement Products ... tournament week by heading to Woodlands, TX for the ... the tournament, Stryker continues to invest in its goal ... health and mobility. As part of the comeback to ... new features to enhance the fan experience at its ...
(Date:4/28/2015)... 2015 Recent Highlights: ... patient in PerClot ® IDE CryoLife, ... and tissue processing company focused on cardiac and vascular ... of 2015.  Pat Mackin, Chairman, President ... milestones regarding two of our top organizational objectives.  First, ...
Breaking Medicine Technology:Semler Adds Top Insurance Plan to Customer List 2Semler Adds Top Insurance Plan to Customer List 3The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 2The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 3The Stryker Mobility Zone Heads to Insperity Invitational for Second Consecutive Year 4CryoLife Reports First Quarter Results 2CryoLife Reports First Quarter Results 3CryoLife Reports First Quarter Results 4CryoLife Reports First Quarter Results 5CryoLife Reports First Quarter Results 6CryoLife Reports First Quarter Results 7CryoLife Reports First Quarter Results 8CryoLife Reports First Quarter Results 9
... AAHC Calls for National Entity to Address Workforce ... center CEOs told congressional staff and representatives of ... that pending health reform legislation does not yet ... to implement successful health system reform. "Pending ...
... AMN Healthcare Services, Inc. (NYSE: AHS ), the ... its quarterly conference call to discuss third quarter results on ... company also expects to issue an earnings news release on ... approximately 4:00 p.m. Eastern Time. , A live webcast of ...
Cached Medicine Technology:Health Reform Bills Still Lack Strategic Focus on Health Workforce 2AMN Healthcare Services to Host 2009 Third Quarter Earnings Conference Call on Thursday, October 29, 2009 2
(Date:4/28/2015)... April 28, 2015 MSA Executive ... executive search, announced today that it has been retained ... Operating Officer search for The Queen's Health ... Reporting to QHS President & CEO Arthur A. Ushijima, ... have operating responsibility for the Queen’s Medical Center Punchbowl ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Brain: The ... American Museum of Natural History, will open at the ... supported by sponsorship from Saint Luke’s Health System. Coming ... City, Toronto, Granada and Milan, this one-of-a-kind exhibition brings ... and technology. , “Saint Luke’s and Museum at ...
(Date:4/28/2015)... April 28, 2015 An Allegheny ... A. Jobe, MD, FACS , has launched the first ... with extracellular matrix (ECM) can help patients who are ... esophageal cancer. , ECM is a complex mixture of ... and migration and signals that guide cell behavior. ECM, ...
(Date:4/28/2015)... A new survey from National Stroke ... 66 percent of Americans fear brain damage the most. ... in May, shed light on the need for greater awareness ... a stroke. By controlling modifiable risk factors, 80 percent ... a “ brain attack ” that occurs when blood flow ...
(Date:4/28/2015)... 28, 2015 New and more ... more of manufacturers, payers, pharmacists and patients. Now ... journal, is partnering with the National Association of ... dedicated solely to this developing field to better ... growing need. , “This partnership creates a powerful ...
Breaking Medicine News(10 mins):Health News:The Queen’s Health Systems Retains MSA Executive Search to Recruit Executive Vice President & Chief Operating Officer 2Health News:Saint Luke's Health System to sponsor Brain: The Inside Story exhibition at Museum at Prairiefire 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 3Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4
... Expectant mothers who have lower intake of folic acid ... higher chance of having babies with low birth weight ... Tyne, UK, had found that increased levels of folic ... of newborns, and vice versa. ,Researchers have examined ...
... combing of wet hair may be far more effective ... ,Researchers have used single blind randomized controlled trial for ... insecticide treatments against head lice in United Kingdom. , ... effective than current over the counter chemical treatments for ...
... to mothers who have low levels of foliate// in their ... ,Folate is essential for fetal growth and gene expression. ... and maintain new cells. It is a B vitamin and ... ,Women are usually prescribed folic acid supplements, a synthetic ...
... of $7 million for upgrading a medical college in ... Sardar Vallavbhai Patel Postgraduate Institute of Paediatrics (in Cuttack) ... dispensation of healthcare to a wider population," said a ... the project were signed and exchanged here Thursday by ...
... memories of unpleasant experiences with unhealthy foods could be ... Loftus of the University of California, Irvine, and her ... eating strawberry ice cream as a child. , ... about food. The volunteers subsequently received feedback on their ...
... Researchers have developed a portable la-chip called Genotyper that ... within hours and help the doctors to treat patients ... the Genotyper is on its way to become fully ... all around the world to track the various flu ...
Cached Medicine News:Health News:Study Links Folic Acid With Increased Birth Weight 2Health News:Combing Hair More Effective Than OTC Medicine For Head Lice 2Health News:Vitamin Supplements During Pregnancy to Boost Fetal Development 2Health News:Unpleasant Memory of Food could Be Used to Treat Obesity 2Health News:New Tools To Identify Flu Strains 2
Curved shafts with 2.0 mm wide serrated tips and 0.4 mm pin in upper jaw. Serrated cross action handle with dull finish....
... insertions of the latest designs of foldable lenses. ... migration of the lens from the grasp of ... manipulations of the instrument for precise release in ... ease of loading and release of the lens. ...
Bi-angled insertion jaws designed to enhance surgeon comfort and efficiency. Reverse action releases lens when handle is compressed. Made in titanium....
Titanium. Curved 18 mm shafts with 1.5 wide grasping tip. Flat, serrated cross action handle with dull finish....
Medicine Products: